Broncus Holding Corporation (Broncus-B) filed its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming that there were no changes to its authorised, issued or treasury share balances during the month.

The company’s authorised share capital stayed at 2.00 billion ordinary shares with a par value of USD 0.000025 each, representing total authorised capital of USD 50,000. Issued shares (excluding treasury shares) closed the month unchanged at 527.08 million, while treasury shares remained at 1.66 million, leaving total issued shares at 528.74 million.

Broncus-B confirmed that it continued to meet the Main Board’s minimum 25% public-float requirement as of 30 June 2026.

Equity incentive activity was minimal: • Share Incentive Plan (adopted 9 May 2021): 3.12 million options outstanding; no grants, exercises, cancellations or lapses occurred, and no shares were issued or transferred from treasury. • RSU Scheme (amended 25 Oct 2023): no shares were issued or transferred, and no units were outstanding.

No warrants, convertibles or other share-linked instruments were outstanding or exercised during the month. Consequently, total funds raised from option exercises were HKD 0.

The filing, signed by Director Xu Hong on 7 July 2026, indicates a stable capital structure with no dilution events in June and full compliance with Hong Kong Stock Exchange listing requirements.